SCHEMBL7236537

SCHEMBL7236537

CC(=O)C1CCc2ccccc2NN1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMYD3 Q9H7B4 1/20 0.44
▸ MTNR1A P48039 7/20 0.42
▸ MTNR1B P49286 3/20 0.40
▸ MAPT P10636 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ NPC1 O15118 1/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ MAPK12 P53778 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ PTK2B Q14289 1/20 0.35
▸ HTR1A P08908 2/20 0.35
▸ HTR2A P28223 2/20 0.35
▸ DRD3 P35462 2/20 0.35
▸ MASP2 O00187 1/20 0.35
▸ F2 P00734 1/20 0.35
▸ HSD17B3 P37058 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PYGL P06737 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30357987 0.83 SMYD3 (0.56) SMYD3MTNR1AMTNR1BMAPTGAA
SCHEMBL5245111 0.83 SMYD3 (0.56) SMYD3MTNR1AMTNR1BMAPTGAA
SCHEMBL4019694 0.73 SMYD3 (0.58) SMYD3MTNR1AMTNR1BMAPTGAA
SCHEMBL1531662 0.71 GAA (0.69) SMYD3MTNR1AMAPTGAAHTR1A
SCHEMBL444953 0.71 GAA (0.69) SMYD3MTNR1AMAPTGAAHTR1A
SCHEMBL1150614 0.71 GAA (0.69) SMYD3MTNR1AMAPTGAAHTR1A
SCHEMBL29831598 0.71 GAA (0.69) SMYD3MTNR1AMAPTGAAHTR1A
Hydrochloric Acid SCHEMBL11047643 0.70 GAA (0.67) SMYD3MTNR1AMAPTGAAHTR1A
Hydrochloric Acid SCHEMBL11050093 0.70 GAA (0.67) SMYD3MTNR1AMAPTGAAHTR1A
Hydrochloric Acid SCHEMBL3157936 0.70 GAA (0.67) SMYD3MTNR1AMAPTGAAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503900-B2 For treatment or prevention of disorders such as obsessive-compulsive disorder, depression, anxiety, schizophrenia WYETH 2003-01-07 — — US disclosed
US-20020086860-A1 [1,4]Diazepino [6,7,1-jk] carbazoles and derivatives AMERICAN HOME PRODUCTS CORPORATION 2002-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020086860-A1 [1,4]Diazepino [6,7,1-jk] carbazoles and derivatives GRIK1, GRIK3, GRIK4 SMYD3 1067/4885MTNR1A 1027/4885MTNR1B 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback